Gain of Iq25-32, 12q23-24.3, 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer

Journal of Pathology

Volumn 210, Issue 2, 2006, Pages 205-213

  Ma, J ^a,b   Gao, M ^b   Lu, Y ^c,d   Feng, X ^b   Zhang, J ^b   Lin, D ^b   Xiao, T ^b   Hu, Z ^b   Yuan, J ^b   Su, K ^b   Shipley, J ^c   Xue, J ^a   Gao, Y ^b  

^a FUDAN UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Comparative genomic hybridization; Laminin5 2; Precancerous lesion; Squamous cell lung cancer; Tissue microarrays

Indexed keywords

KALININ; TUMOR MARKER; LAMC2 PROTEIN, HUMAN; LAMININ; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CHROMOSOME 12Q; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME IDENTIFICATION; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC GAIN; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG DYSPLASIA; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; SQUAMOUS CELL METAPLASIA; CANCER STAGING; CELL TRANSFORMATION; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 17; DISEASE COURSE; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; METHODOLOGY; MICRODISSECTION; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; FEMALE; HUMANS; LAMININ; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; PRECANCEROUS CONDITIONS;

EID: 33749045025     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2050     Document Type: Article

References (47)

1. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999;86:1867-1876.
2. Travis WD, Colby TV, Shimosato Y, Corrin B, Brambilla E in association with Sobin LH and pathologists from 14 other countries. WHO/IASLC Classification of Lung and Pleural Tumors (3rd edn). Springer-Verlag: Berlin, 1999.
3. Franklin WA, Wistuba II, Geisinger K, Lam S, Hirsch FR, Muller KM, et al. Squamous dysplasia and carcinoma in situ. In Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, World Health Organization Classification of Tumours, Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds). IARC Press: Lyon, 2004.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
5. Gazdar A, Franklin WA, Brambilla E, Hainaut P, Yokota J, Harris CC. Genetic and molecular alterations. In Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, World Health Organization Classification of Tumours, Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds). IARC Press: Lyon, 2004.
6. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic, hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.
7. Petersen S, Aninat-Meyer M, Schluns K, Gellert K, Dietel M, Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 2000;82:65-73.
8. Masuda A, Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 2002;21:6884-6897.
9. Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, et al. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer 2001;31:282-287.
10. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877-6883.
11. Lu YJ, Dong XY, Shipley J, Zhang RG, Cheng SJ. Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma. Lung Cancer 1999;23:61-66.
12. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998;90:697-703.
13. Chung GT, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. Sequential molecular genetic changes in lung cancer development. Oncogene 1995;11:2591-2598.
14. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-650.
15. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;273:1908.
16. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992;52:6079-6082.
17. Nishisaka T, Takeshima Y, Inai K. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients. Hiroshima J Med Sci 2000;49:109-116.
18. Lu YJ, Dong XY, Guo SP, Zhang RG, Ke Y, Zhang LZ, et al. 2q-, a non-random chromosomal abnormality in human non-small-cell lung cancer. Carcinogenesis 1996;17.1589-1593.
19. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-862.
20. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89:1366-1373.
21. Rook MS, Delach SM, Deyneko G, Worlock A, Wolfe JL. Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping. Am J Pathol 2004;164:23-33.
22. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma insitu and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998;58:4721-4727.
23. Solinas-Toldo S, Durst M, Lichter P. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. Proc Natl Acad Sci USA 1997;94:3954-3959.
24. Hu Z, Lin D, Yuan J, Xiao T, Zhang H, Sun W, et al. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res 2005;11:4646-4652.
25. Yamamoto H, Itoh F, Iku S, Hosokawa M, Imai K. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin Cancer Res 2001;7:896-900.
26. Sun W, Zhang K, Zhang X, Lei W, Xiao T, Ma J, et al. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. Cancer Lett 2004;212:83-93.
27. Tarafa G, Prat E, Risques RA, Gonzalez S, Camps J, Grau M, et al. Common genetic evolutionary pathways in familial adenomatous polyposis tumors. Cancer Res 2003;63:5731-5737.
28. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-627.
29. Haruki N, Harano T, Masuda A, Kiyono T, Takahashi T, Tatematsu Y, et al. Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am J Pathol 2001;159:1345-1352.
30. Lengauer C. How do tumors make ends meet? Proc Natl Acad Sci USA 2001;98:12331-12333.
31. Bjorkqvist AM, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Tammilehto L, Mattson K, et al. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer 1998;22:79-82.
32. Foster NA, Barterjee AK, Xian J, Roberts I, Pezzella F, Coleman N, et al. Somatic genetic changes accompanying lung tumor development. Genes Chromosomes Cancer 2005;44:65-75.
33. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003;63:7113-7121.
34. Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004;36:984-988.
35. Katayama M, Sekiguchi K. Laminin-5 in epithelial tumour invasion. J Mol Histol 2004;35:277-286.
36. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997;277:225-238.
37. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, et al. Differential regulation of cell motility and invasion by FAK. J Cell Biol 2003;160:753-767.
38. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-826.
39. Katayama M, Sanzen N, Funakoshi A, Sekiguchi K. Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res 2003;63:222-229.
40. Olsen J, Kirkeby LT, Brorsson MM, Dabelsteen S, Troelsen JT, Bordoy R, et al. Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells. Biochem J 2003;371-211-221.
41. Kusakai G, Suzuki A, Ogura T, Miyamoto S, Ochiai A, Kaminishi M, et al. ARK5 expression in colorectal cancer and its implications for tumor progression. Am J Pathol 2004;164:987-995.
42. Muller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schwable J, et al. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 2005;65:1778-1782.
43. Volm M, Koomagi R, Mattern J, Efferth T. Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases. Clin Exp Metastasis 2002;19:385-390.
44. Ottesen GL. Carcinoma in situ of the female breast. A clinico-pathological, inummohistological, and DNA ploidy study. APMIS 2003(Suppl):;1-67.
45. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
46. Lu YJ, Hing S, Williams R, Pinkerton R, Shipley J, Pritchard-Jones K. UK Children's Cancer Study Goup Wilms' tumor group. Chromosome 1q expression profiling and relapse in Wilms' tumour, Lancet 2002;360:385-386.
47. Schwendel A, Langreck H, Reichel M, Schrock E, Ried T, Dietel M, et al. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer 1997;74:86-93.